The coronavirus-induced COVID-19 pandemic Previous experiences and scientific evidences at the end of March, 2020

被引：15
作者：
Varadi Andras [1 ]
Ferenci Tamas [2 ,3 ]
Falus Andras [4 ,5 ]
机构：
[1] Magyar Tud Acad, Termeszettudomanyi Kutatokozpont, Enzimol Int, Budapest, Hungary
[2] Obudai Egyet, Elettani Szabalyozasok Kutatokozpont, Budapest, Hungary
[3] Budapesti Corvinus Egyet, Kozgazdasagtudomanyi Kar, Stat Tanszek, Budapest, Hungary
[4] Semmelweis Egyet, Altalanos Orvostudomanyi Kar, Sejt & Imunbiol Int, Budapest, Hungary
[5] Magyar Tud Acad, Egeszsegneveles Kortarsoktatassal TANTUdSZ Kutato, Budapest, Hungary
来源：
ORVOSI HETILAP | 2020年 / 161卷 / 17期
关键词：
coronavirus; COVID-19; viral pandemics; viral vaccines; testing; RT-PCR; reverse transcriptase polymerase chain reaction; RESPIRATORY SYNDROME CORONAVIRUS; SARS CORONAVIRUS; IMMUNE-RESPONSES; VACCINES; MICE; DNA;
D O I：
10.1556/650.2020.31830
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The COVID-19 epidemic hit everyone, professionals and civilians alike. The possibility of a worldwide pandemic has long been theorized by epidemiologists, infectologists on the one hand, and sociologists and behavioral scientists dealing with communication and social habits on the other. Yet, faced with real-time events, daily infections and mortality statistics, almost everyone feels uninformed or disturbingly inexperienced. This summary aims to provide an overview of the latest scientific evidences. Of course, the incomplete material, compiled in late March 2020, will certainly contain a few elements that likely will be outdated in a few weeks. The authors hope that in the next publication we will all read much better and more hopeful prospects.
引用
收藏
页码：644 / 651
页数：8
相关论文
共 26 条
[1]  
Adams S, 2019, ANN ONCOL, V30, P405, DOI [10.1093/annonc/mdy518, 10.1093/annonc/mdy517]
[2]   Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies [J].
Ahmed, Syed Faraz ;
Quadeer, Ahmed A. ;
McKay, Matthew R. .
VIRUSES-BASEL, 2020, 12 (03)
[3]  
BioSpace, 2020, COD SER I IND IN COD
[4]   A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response [J].
Bolles, Meagan ;
Deming, Damon ;
Long, Kristin ;
Agnihothram, Sudhakar ;
Whitmore, Alan ;
Ferris, Martin ;
Funkhouser, William ;
Gralinski, Lisa ;
Totura, Allison ;
Heise, Mark ;
Baric, Ralph S. .
JOURNAL OF VIROLOGY, 2011, 85 (23) :12201-12215
[5]   The convalescent sera option for containing COVID-19 [J].
Casadevall, Arturo ;
Pirofski, Liise-Anne .
JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (04) :1545-1548
[6]   Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate [J].
Chen, Wen-Hsiang ;
Chag, Shivali M. ;
Poongavanam, Mohan V. ;
Biter, Amadeo B. ;
Ewere, Ebe A. ;
Rezende, Wanderson ;
Seid, Christopher A. ;
Hudspeth, Elissa M. ;
Pollet, Jeroen ;
McAtee, C. Patrick ;
Strych, Ulrich ;
Bottazzi, Maria Elena ;
Hotez, Peter J. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (08) :1961-1970
[7]   Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice [J].
DeDiego, Marta L. ;
Pewe, Lecia ;
Alvarez, Enrique ;
Rejas, Maria Teresa ;
Perlman, Stanley ;
Enjuanes, Luis .
VIROLOGY, 2008, 376 (02) :379-389
[8]  
European Commission, NEW CONTR MAT DEV JR
[9]   RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial (Retracted article. See vol. 65, 2025) [J].
Gautret, Philippe ;
Lagier, Jean-Christophe ;
Parola, Philippe ;
Van Thuan Hoang ;
Meddeb, Line ;
Mailhe, Morgane ;
Doudier, Barbara ;
Courjon, Johan ;
Giordanengo, Valerie ;
Vieira, Vera Esteves ;
Dupont, Herve Tissot ;
Honore, Stephane ;
Colson, Philippe ;
Chabriere, Eric ;
La Scola, Bernard ;
Rolain, Jean-Marc ;
Brouqui, Philippe ;
Raoult, Didier .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (01)
[10]  
Gordon David E, 2020, bioRxiv, DOI 10.1101/2020.03.22.002386
123